Team:Potsdam Bioware

From 2012.igem.org

(Difference between revisions)
(Project Description)
(Project Description)
Line 35: Line 35:
-
 
-
{|align="justify"
 
-
|You can write a background of your team here.  Give us a background of your team, the members, etc.  Or tell us more about something of your choosing.
 
-
|[[Image:Potsdam_Bioware_logo.png|200px|right|frame]]
 
-
|-
 
-
|
 
-
''Tell us more about your project.  Give us background.  Use this as the abstract of your project.  Be descriptive but concise (1-2 paragraphs)''
 
-
|[[Image:Potsdam_Bioware_team.png|right|frame|Your team picture]]
 
-
|-
 
-
|
 
-
|align="center"|[[Team:Potsdam_Bioware | Team Potsdam_Bioware]]
 
-
|}
 
-
-->
 
-
<!--- The Mission, Experiments --->
 

Revision as of 22:45, 31 August 2012


Direct Antibody Identification, Maturation and Production in CHO-Cells

Project Description


Antibodies are versatile molecules for research and therapy and they are currently revolutionizing the market of biopharmaceuticals. To date, antibodies are generated in a laborious and time consuming manner. Either animal immunization followed by hybridoma technology or phage display is used to identify desired genes, which then need to be transferred to a production cell line such as CHO. We designed a streamlined workflow that incorporates all steps of antibody generation in CHO cells. Our plan is to stably transfect an antibody-fragment library in CHO cells. Antibody maturation is mimicked by further diversifying this library using the enzyme Activation-Induced cytidine Deaminase (AID), which is known to induce somatic hypermutation. Next, we plan to test and deploy a versatile and continuous viral selection system for clones producing the desired antibodies. Finally, we will try to employ a genetic switch to go from surface expression to soluble production of antibodies.



Team

Mario Köhler
Tom Scheidt
Christopher Kressler
Tobias Priemel
Maria Kunert
Sascha Lehnort
Norman Hein